Phorbol ester phorbol-12-myristate-13-acetate induces epithelial to mesenchymal transition in human prostate cancer ARCaPE cells (scientific article published on July 2010)

The selective protein kinase C inhibitor GF 109203X inhibits phorbol ester-induced morphological and functional differentiation of SH-SY5Y human neuroblastoma cells

Q41507925

Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model

Q41902936

Inflammation and tumor promotion: selective protein induction in mouse skin by tumor promoters

Q69413276

Tumor-promoting activity of phorbol and four diesters of phorbol in mouse skin

Q70537945

Studies of the differentiation of promyelocytic cells by phorbol ester. I. Induction of discrete membrane proteins characteristic of monocytes and expression of motility functions in HL-60 cells following differentiation by phorbol ester

Q70933178

Functional responses of tumor cells to phorbol esters: role for prostaglandins

Q70943094

The sevenfold way of PKC regulation

Q77483361

Protein kinase C iota: human oncogene, prognostic marker and therapeutic target

Q24652905

Balancing cell adhesion and Wnt signaling, the key role of beta-catenin

Q28288763

The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C

Q28327651

An overview of epithelio-mesenchymal transformation

Q30014826

Establishment of human prostate carcinoma skeletal metastasis models

Q30305852

Mechanisms, mechanics and function of epithelial-mesenchymal transitions in early development

Q30311953

PKC eta as a therapeutic target in glioblastoma multiforme

Q30437051

Androgen-repressed phenotype in human prostate cancer

Q30454285

Modulation of protein kinase C in antitumor treatment

Q31974504

PI-3 kinase in signal transduction, cell transformation, and as a target for chemoprevention of cancer.

Q33811311

Transitions between epithelial and mesenchymal states in development and disease

Q34761972

Epithelial-mesenchymal transitions: a mesodermal cell strategy for evolutive innovation in Metazoans.

Q34969022

Expression of E-cadherin in primary and metastatic prostate cancer.

Q35773636

Cadherins and catenins in breast cancer

Q36233642

Skin tumor promotion by phorbol esters is a two-stage process

Q36384287

The E-cadherin-beta-catenin complex and its implication in lung cancer progression and prognosis

Q36429579

Epithelial-mesenchymal transition in prostate cancer and the potential role of kallikrein serine proteases

Q36857803

Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression.

Q36902961

The therapeutic role of targeting protein kinase C in solid and hematologic malignancies

Q36964732

Targeting the oncogenic protein kinase Ciota signalling pathway for the treatment of cancer

Q36979513

Potential role of PKC inhibitors in the treatment of hematological malignancies

Q37239896

Structural and functional diversities of a family of signal transducing protein kinases, protein kinase C family; two distinct classes of PKC, conventional cPKC and novel nPKC.

Q37261630

Exploitation of protein kinase C: a useful target for cancer therapy

Q37263545

Progressive epithelial to mesenchymal transitions in ARCaP E prostate cancer cells during xenograft tumor formation and metastasis

Q38570292

A molecular signature for Epithelial to Mesenchymal transition in a human colon cancer cell system is revealed by large-scale microarray analysis.

Q39865031

Receptor activator of NF-kappaB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells.

Q39958524

Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells

Q39996197

Prostate cancer metastasis: role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis

Q40244672

Transformations between epithelium and mesenchyme: normal, pathological, and experimentally induced

Q40421321

The potential of protein kinase C as a target for anticancer treatment

Q40815216

Intermediate filament expression in prostate cancer

Q41349162

P433

issue

P921

main subject

prostate cancer

Q181257

P304

page(s)

1119-1126

P577

publication date

2010-07-01

P1433

published in

The Prostate

Q7758608

P1476

title

Phorbol ester phorbol-12-myristate-13-acetate induces epithelial to mesenchymal transition in human prostate cancer ARCaPE cells

P478

volume

Reverse relations

cites work (P2860)

Q34586273	Activation of PKCβII by PMA facilitates enhanced epithelial wound repair through increased cell spreading and migration
Q34056549	Chromatinized protein kinase C-θ directly regulates inducible genes in epithelial to mesenchymal transition and breast cancer stem cells
Q34271512	Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition
Q35918045	Differential Roles for DUSP Family Members in Epithelial-to-Mesenchymal Transition and Cancer Stem Cell Regulation in Breast Cancer
Q36028764	Effects of Panax notoginseng on the Metastasis of Human Colorectal Cancer Cells
Q47222619	LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer.
Q35112032	Metastatic breast cancer cells in the bone marrow microenvironment: novel insights into oncoprotection
Q39396694	Obesity-related systemic factors promote an invasive phenotype in prostate cancer cells
Q36240981	Protein kinase C inhibitor Gö6976 but not Gö6983 induces the reversion of E- to N-cadherin switch and metastatic phenotype in melanoma: identification of the role of protein kinase D1
Q39429708	Protein kinase Cα inhibitor enhances the sensitivity of human pancreatic cancer HPAC cells to Clostridium perfringens enterotoxin via claudin-4.
Q37687624	STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways
Q36368188	Secreted Hsp90 is a novel regulator of the epithelial to mesenchymal transition (EMT) in prostate cancer.
Q37848782	Steps in prostate cancer progression that lead to bone metastasis
Q38242808	Targeting tight junctions during epithelial to mesenchymal transition in human pancreatic cancer.